Antonio C.
- Country
- Italy
- Department
- #40830: UO Dermatologia
Research Overview
- B7981040 - A PHASE 3 RANDOMIZED, DOUBLE-BLIND, 52-WEEK PLACEBOCONTROLLED, MULTI-CENTER STUDY INVESTIGATING THE EFFICACY, SAFETY, AND TOLERABILITY OF RITLECITINIB IN ADULT AND ADOLESCENT PARTICIPANTS WITH NONSEGMENTAL VITILIGO
- Phase IIb Randomized, Double‑Blind, Dose‑Ranging Study of Subcutaneous GIA632 for Facial Repigmentation in Adults with Non‑segmental Vitiligo
- Evaluation of Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Amlitelimab in Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
Data & Insights
Has run more than one trial at 410 of 680 partner sites.
Specializations
Inflammatory Skin Conditions
This investigator specializes in treating severe inflammatory dermatological conditions, with particular focus on plaque psoriasis and atopic dermatitis. Their research encompasses both established and innovative therapeutic approaches.
- Moderate to severe plaque psoriasis
- Atopic dermatitis management
- Chronic skin inflammation
Autoimmune Skin Disorders
The investigator conducts research in autoimmune dermatological conditions, including vitiligo and alopecia areata. Their work extends to various manifestations of autoimmune responses in the skin.
- Non-segmental vitiligo treatment
- Alopecia areata interventions
- Bullous pemphigoid research
Complex Dermatological Conditions
Focus areas include hidradenitis suppurativa, chronic spontaneous urticaria, and prurigo nodularis. The investigator studies innovative therapeutic approaches for these challenging conditions.
- Hidradenitis suppurativa management
- Chronic urticaria treatment
- Pruritus and skin manifestations
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.